Jul 2, 2025 · Two oral presentations to highlight the safety, immunogenicity, and future development of AV-1959R for primary and secondary prevention of Alzheimer's disease.

Jul 7, 2025 · Two oral presentations to highlight the safety, immunogenicity, and future development of AV-1959R for primary and secondary prevention of Alzheimer's disease.

11 hours ago · Vaccines may reduce risk of Alzheimer’s Research from the University of Texas’ McGovern Medical School found that an annual flu vaccine was linked to a 40% decrease in risk of …

Nuravax Inc. has announced that two oral presentations on its amyloid-beta vaccine, AV-1959R, will be featured at the 18th Clinical Trials on Alzheimer's Disease conference in December 2025.

Jan 17, 2019 · More than a decade ago, Alzheimer’s vaccines appeared in clinical trials — but failed. Now several companies are gearing up to test the next generation of preventive treatments.

Jul 21, 2025 · The University of New Mexico has received critical early-phase funding to support the launch of a clinical trial for a new Alzheimer’s vaccine, developed by scientists at the University of …

Aug 4, 2025 · Data presented at AAIC 2025 from a phase 2 study suggest that ABvac40 may slow cognitive decline in patients with Alzheimer disease, particularly among those who developed higher …

Apr 24, 2025 · Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by generating a strong immune response against abnormal tau …

May 1, 2025 · Researchers at the University of New Mexico Health Sciences are preparing to initiate human clinical trials for a promising new vaccine aimed at preventing the accumulation of …

Jul 14, 2025 · University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to clear pathological tau protein from the brains of patients …